Specifications

• Konjugation:
  Unconjugated
• Protein/Peptid-Typ:
  Rekombinant
• Ursprung:
  HEK293 cells
• Spezies:
  Human
• Tag sequence:
  His Tag (BLI verified)
• Lagerbedingungen:
  –20 °C
• Endotoxingehalt:
  Less than 1,0 EU per μg by the LAL method.
• Biologische Aktivität:
  Immobilised Human CD32a (R167), His Tag (BLI verified) (Cat. No. CDA-H5221) on CM5 Chip via anti-His antibody, can bind  Rituximab with an affinity constant of 3.12 μM as determined in a SPR assay (Biacore T200) (Routinely tested). Loaded Rituximab on Protein A Biosensor, can bind Human CD32a (R167), His Tag (BLI verified) (Cat. No. CDA-H5221) with an affinity constant of 1,5 μM as determined in BLI assay (ForteBio Octet Red96e) (QC tested). Loaded Human CD32a (R167), His Tag (BLI verified) (Cat. No. CDA-H5221) on HIS1K Biosensor, can bind Rituximab with an affinity constant of 1,4 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
• Gen-ID:
  P12318-1 (R167)
• Proteinsynonym:
  CD32|CD32a|IGFR2|FCGR2A1|FCG2 |FCGR2A
• Protein/Peptid-Name:
  Fc gamma RIIA/ CD32a
• Purity:
  >95% as determined by SDS-PAGE.
• Molecular weight:
  21,6 kDa
• Endotoxinspiegel:
  Low
• Zusammensetzung:
  Lyophilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation.
• Transporttemperatur:
  RT